American Chemical Society--236th National Meeting & Exposition. Drug development for tuberculosis and cancer.
Rotella
David P
DP
Wyeth Research, CN 8000, Princeton, NJ 08543, USA. rotelld@wyeth.com
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000494:pharmacology*; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D016547:Kinesins / Q000037:antagonists & inhibitors / Q000378:metabolism; D000071137:Poly (ADP-Ribose) Polymerase-1; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors; D014748:Vinca Alkaloids / Q000494:pharmacology
D000970:Antineoplastic Agents; D000995:Antitubercular Agents; C470243:KIF11 protein, human; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D047428:Protein Kinase Inhibitors; D014748:Vinca Alkaloids; C499320:PARP1 protein, human; D000071137:Poly (ADP-Ribose) Polymerase-1; D019859:Proto-Oncogene Proteins c-met; D016547:Kinesins